Article
Eli Lilly extends tender offer to buy Point Biopharma after low participation
Rating:
0.0
Views:
45
Likes:
1
Library:
1
Eli Lilly on Friday extended the deadline for Point Biopharma Global shareholders by about two weeks to Dec. 1 to sell their stock, due to low participation.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value